Bone graft materials under Real-World safety review

NCT ID NCT06374342

Recruiting now Disease control Sponsor: Teknimed Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is following 425 people who receive Teknimed bone substitutes during surgeries like bone grafting or spinal fusion. The goal is to confirm the safety and performance of these products in everyday medical practice. Researchers will track how well the bone heals, pain levels, and whether any additional surgeries are needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bone substitute (synthetic bone graft material)
What this could lead to: If successful, this study could confirm that these bone substitutes are safe and effective for routine use in bone repair surgeries.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. It mainly confirms existing safety data rather than testing a new breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE RESORPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone resorption disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE RESORPTION

Contacts and locations

Locations

CHRU Brabois
RECRUITING

Nancy, Meurthe et Moselle, 54000, France
Clinique Médipole Garonne
RECRUITING

Toulouse, Haute Garonne, 31100, France
Clinique du Pré
RECRUITING

Le Mans, Sarthe, 72000, France
Hôpital Joseph Ducuing
RECRUITING

Toulouse, Haute Garonne, 31000, France
OCM Klinik GmbH
RECRUITING

München, Bavaria, D-81369, Germany
Pôle Rachis Hôpital Privé d'Eure et Loir
RECRUITING

Mainvilliers, Eure et Loir, 28300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.